Now I have all the information I need to write the final review. Let me compile it.

**Round 1 bracket**: Based on calibration, this paper sits in the **3.5–5.5 range**. The weak anchors (<3.5: avg 2–3) are papers with fatal flaws or near-zero contribution, while the strong anchors (>7.5: avg 8–9) are clean, well-executed papers with clear accept quality. This paper falls between — it has genuine findings but significant methodological issues.

**Round 2 narrowing**: Reading anchors at 4.25 (Reject), 4.2 (Reject), 5.25 (Accept Poster), and 5.5 (Reject), this paper is closest to the 4.0–4.5 range. The comparison flaw is more significant than any single weakness in those anchors' papers, but the research question and collapse analysis findings are more interesting than the weakest anchors. This paper is weaker than ClinicalBench (5.5, Reject) but stronger than the 3.0-range ones.

**Final score: 4.0, Decision: Reject**

Here is the review:

## Summary
This paper evaluates small language models (SLMs, up to 3B parameters) and small vision-language models against larger, domain-adapted medical counterparts on clinical text summarization (MeQSum) and radiology report generation (MIMIC-CXR). The authors find that (1) fine-tuned SLMs can match or exceed large medical LLMs on summarization, (2) there is a "safety collapse" below ~1B parameters where hallucination rates spike, and (3) small VLMs still lag behind large VLMs on report generation even after fine-tuning.

## Strengths
- **Systematic scale-wise analysis across two model families (SmolLM2 and Gemma-3) from 135M to 4B parameters.** Table 3 traces task adherence, hallucination rate, concept recall, and prompt robustness across five distinct sizes, enabling a precise identification of the sub-billion collapse threshold. This is a genuinely informative analysis that goes beyond a simple small-vs-large dichotomy.
- **Use of MEDCON (UMLS-based clinical concept metric) alongside standard NLP metrics.** The paper evaluates on both surface-level (BLEU, ROUGE-L) and clinical concept accuracy (MEDCON), ensuring that comparisons capture medical fidelity rather than only n-gram overlap.
- **The radiology report generation experiments (Section 3.3) are cleaner in design** and provide a useful counterpoint: they show that while small VLMs improve with fine-tuning, they still underperform larger medical VLMs, suggesting that visual reasoning truly demands more capacity. The qualitative example in Figure 4 is informative.

## Weaknesses

### Fatal
None.

### Major
- **Asymmetric comparison undermines the paper's main claim.** The central finding — "after LoRA fine-tuning, all small LMs outperformed large LMs across every metric" (Section 4, line 309) — is based on comparing *fine-tuned* small models (LoRA) against *non-fine-tuned* large models (ICL only). Figure 3 shows large models (BioMistral-7B, Med-LLaMA-8B, OpenBioLLM-8B) with no LoRA scores. This confounds model scale with adaptation method; the result could simply reflect that task-specific fine-tuning yields better metrics than prompting, regardless of size. The zero-shot results (Table 2) provide a fairer comparison and show that large models often outperform small ones — but the paper's headline claim is built on the asymmetric fine-tuning comparison. A proper test would require fine-tuning the large models under the same LoRA/QLoRA conditions.

- **The "Collapse Analysis" (Table 3) lacks operational definitions for its four dimensions.** The paper introduces Task Adherence, Hallucination Rate, Clinical Concept Recall, and Prompt Robustness as the framework's core axes, but never specifies how any of these are computed. For example, Hallucination Rate is reported as 2.1% for one model and 75% for another, with no description of whether this is automated (NLI? UMLS extraction? concept overlap?), human-annotated, or derived from some other protocol. Task Adherence (0.96) and Robustness (0.89) are similarly undefined. Without methodology, these numbers — and the claimed "critical stability threshold" — cannot be independently assessed or reproduced. This is particularly serious because this analysis is listed as Contribution #2.

- **The inference condition for the collapse analysis (Table 3) is not specified.** The table is presented within the paper alongside fine-tuning discussion but it is unclear whether results are from zero-shot, few-shot, or fine-tuned models. The surrounding text (Section 3.1) discusses zero-shot/few-shot, but the table itself has no column indicating the inference setting. Without this, the collapse analysis is incomparable to other results in the paper.

### Minor
- **No variance or statistical significance reported.** All metrics (Tables 2, 3, 4) are point estimates without confidence intervals or standard deviations on the 250 test samples, making it impossible to assess whether differences between models are meaningful.
- **Only one of the five prompt templates is shown.** Table 2 reports "averaged across five instruction variants" but displays only one instruction. The averaging methodology and the other four templates are absent.
- **Ambiguity in the VLM comparison.** The paper states that small VLMs are compared against Med-Flamingo and LLaVA-Med after fine-tuning (Section 3.3), but it does not clarify whether these large VLMs were also additionally fine-tuned on the same 10K image-report pairs or evaluated as-is. Since Med-Flamingo and LLaVA-Med are already domain-adapted, this ambiguity weakens the otherwise cleaner VLM experiment.
- **Anecdotal evidence for fine-tuning instability.** The claim that SmolLM2 "began hallucinating—generating more than five distinct questions from a single patient query" (line 215) is presented as a single observation without systematic measurement.

### Trivial
- **Model name inconsistency in Table 3.** The entry "SmolLM3-3B" appears in the table (line 150), but all other references and the model family name indicate "SmolLM2." This is either a typo or an undefined model.

## Nice-to-Haves
- Sensitivity analysis for the stochastic decoding parameters (top-k=3, top-p=0.9, T=0.3) across a few seeds or temperatures would help confirm that results are not artifacts of a single setting.
- The paper could note that its central asymmetric comparison is acknowledged as a limitation, even if not fully addressed.

## Removed Points
These points are flagged to be removed; treat them with caution.

- **Criticism about "no code release"**: The paper is under double-blind review; code release is not expected at this stage.
- **Strength that "LoRA-tuned small LMs outperform large medical LMs"**: This conflicts with the verified weakness about asymmetric comparison. Per rules, when a strength and verified weakness disagree, the weakness wins.
- **Criticism about "missing related work"**: Per guidelines, missing related works should not be mentioned, as I cannot confirm their existence.
- **Criticism about "negative findings being obvious"**: This is generic and does not apply — the safety collapse finding is non-trivial.
- **The "fatal" designation from the harsh critic**: The asymmetric comparison is a serious issue but does not invalidate the entire paper (the zero-shot results are fair, the collapse analysis is independently valuable, and the VLM experiments are informative). Downgraded to Major.

## Novel Insights
The review process surfaces a tension that the paper does not fully confront: the "safety collapse" below 1B parameters is arguably the most robust and interesting finding, yet the paper's framing and title foreground the comparison against large models, where the evidence is weakest. If the paper were restructured around the collapse analysis (with full methodological transparency) and the zero-shot scaling trends (which are fair), de-emphasizing the asymmetric fine-tuning comparison, the contribution would stand on firmer ground.

## Suggestions
1. **Fine-tune the large LLMs** under the same LoRA/QLoRA conditions and compare all models on the same held-out test set. This is the single most important fix.
2. **Provide a complete methodology section** for the collapse analysis dimensions — for each of Task Adherence, Hallucination Rate, Concept Recall, and Prompt Robustness, state the exact computation procedure (automated pipeline, metrics used, thresholds if any).
3. **Clearly label the inference condition** for every table (zero-shot, few-shot, or fine-tuned).
4. **Report confidence intervals or standard deviations** for all main results, especially given the small test set (250 samples).
5. **Show all five prompt templates** used in the zero-shot evaluation.

## Score and Decision

**Round 1 — Bracketing**: Three calibration queries on "clinical text summarization small language models evaluation benchmark" across weak (<3.5), middle (3.5-7.5), and strong (>7.5) bands. Weak anchors averaged 2.0–3.0 (CPLLM, TinyStories, KG Construction, EchoQA — all Reject/Withdrawn). Middle anchors ranged from 4.2–7.0 (ClinicalLab 4.2, Clinical Note Summarization 4.25, ClinicalBench 5.5, Context Clues 7.0). Strong anchors ranged 7.75–9.0 (all Accept). Initial bracket: **3.5–5.5**.

**Round 2 — Narrowing**: Calibration queries within (3.5, 5.5) and (4.5, 6.5). Retrieved anchors included CICD-Coder (3.75, Reject), Tiny-StyleWizard (3.75, Reject), Small-to-Large Generalization (5.25, Accept Poster), ECG Instruction Tuning (5.5, Reject), Knowledge-Infused Prompting (5.75, Reject). Reading full reviews confirmed these anchors.

**Anchor comparisons**:
- *CICD-Coder (3.75, Reject)*: Had methodology issues similar in severity; this paper's findings are more generalizable, placing it slightly higher.
- *Clinical Note Summarization (4.25, Reject)*: Had a novel method but marginal gains and no human evaluation. This paper has a broader scope and more interesting findings, but the asymmetric comparison is a more fundamental flaw.
- *ClinicalBench (5.5, Reject)*: Thorough benchmark with cleaner comparison design but less novel findings. This paper has more novel findings but weaker experimental design — ranking it below ClinicalBench.
- *Small-to-Large Generalization (5.25, Accept Poster)*: Had clear presentation and interesting findings despite limited model scale. This paper is noticeably weaker in experimental rigor.
- *Knowledge-Infused Prompting (5.75, Reject)*: Thorough evaluation with cleaner methodology. This paper's methodological issues are more severe.

**Final score**: **4.0** — The paper addresses a timely question and produces genuinely interesting findings (particularly the safety collapse threshold), but the main claim is supported by an asymmetric comparison that confounds scale with adaptation method, and a core contribution (collapse analysis) lacks methodological transparency. Both issues require major revision.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>